Nanalysis Scientific Corp NSCI
TSXV · Canada · Health Technology
CAD 0.11500.00 (0.00%)
Market open· · CAD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · CAD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Improved cost structure and operational efficiencies drive significant profitability gains despite modest revenue growth.
Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, FRA: 1N1), a leader in portable NMR spectrometers and imaging technology for government, industrial and research applications, announces its financial results for the second quarter ending June 30, 2026. Chief Executive Officer Sean Krakiwsky and Chief Financial Officer Heather Kury will host a conference call at 10 A.M. Eastern Time on Monday August 24th to discuss the results for the second quarter. All interested parties are invited to jo
Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, FRA: 1N1), a leader in benchtop NMR instruments and imaging technology and services for industrial and research applications announces that on Monday, August 24th 2026, the Company will put out a press release before the market opens and Chief Executive Officer Sean Krakiwsky and Chief Financial Officer Heather Kury will host a conference call at 10 A.M. Eastern Time on Monday, August 24th to discuss the results for the second quarter 2026.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.